ReviewCurrent treatment options in neurology2019

Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis.

Anastasie M Dunn-Pirio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.